Top-News

Reshape Lifesciences News

Aktie
WKN:  A2H5ZY ISIN:  US7611231082
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
14,57 Mio.
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 16.08.2018

Reshape Lifesciences News

28.06.21 - PR Newswire
Thinking about buying stock in SoFi Technologies, American Airlines, ReShape Lifesciences, Nokia, or Paysafe?
Thinking about buying stock in SoFi Technologies, American Airlines, ReShape Lifesciences, Nokia, or Paysafe? PR Newswire
21.01.21 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Investigates Obalon Therapeutics, Inc.
SHAREHOLDER ALERT: WeissLaw LLP Investigates Obalon Therapeutics, Inc. PR Newswire
15.09.20 - PR Newswire
First Twenty-five Healthcare Professionals Enrolled in ReShapeCare™, a Reimbursable, Evidence-based Virtual Weight Management Program
First Twenty-​five Healthcare Professionals Enrolled in ReShapeCare™, a Reimbursable, Evidence-​based Virtual Weight Management Program New telehealth program increases ...
10.09.20 - PR Newswire
ReShape Lifesciences™ Announces Positive Preclinical Results for Its Investigational Diabetes Bloc-Stim Neuromodulation Device
ReShape Lifesciences™ Announces Positive Preclinical Results for Its Investigational Diabetes Bloc-Stim Neuromodulation Device Study funded by National Institutes of Health Small ...
31.07.18 - PR Newswire
ReShape Lifesciences Announces European Trial to Support CE-Mark of ReShape Vest
ReShape Lifesciences Announces European Trial to Support CE-Mark of ReShape Vest PR Newswire
11.07.18 - PR Newswire
ReShape Lifesciences Announces $2.7 Million Registered Direct Offering Priced At-the-Market
ReShape Lifesciences Announces $2.7 Million Registered Direct Offering Priced At-​the-Market PR Newswire
27.06.18 - PR Newswire
ReShape Lifesciences Announces Acceptance of Abstract to be Presented at IFSO Annual Conference
ReShape Lifesciences Announces Acceptance of Abstract to be Presented at IFSO Annual Conference PR Newswire
20.06.18 - PR Newswire
ReShape Lifesciences Announces $1.5 Million Registered Direct Offering Priced At-the-Market
ReShape Lifesciences Announces $1.5 Million Registered Direct Offering Priced At-​the-Market PR Newswire
19.06.18 - PR Newswire
ReShape Lifesciences Receives USPTO Issue Notification for Patent Covering its ReShape Vest
ReShape Lifesciences Receives USPTO Issue Notification for Patent Covering its ReShape Vest PR Newswire
07.06.18 - PR Newswire
ReShape Lifesciences Announces $1.5 Million Registered Direct Offering Priced At-the-Market
ReShape Lifesciences Announces $1.5 Million Registered Direct Offering Priced At-​the-Market PR Newswire
06.06.18 - PR Newswire
ReShape Lifesciences Assembles World Class Scientific Advisory Board
ReShape Lifesciences Assembles World Class Scientific Advisory Board PR Newswire
05.06.18 - PR Newswire
ReShape Lifesciences Announces New Patent Grant Expanding its Bioelectronic and Neuromodulation Portfolio
ReShape Lifesciences Announces New Patent Grant Expanding its Bioelectronic and Neuromodulation Portfolio PR Newswire
04.06.18 - PR Newswire
ReShape Lifesciences Provides Update on FDA Letter to Health Care Providers Related to Intragastric Balloons
ReShape Lifesciences Provides Update on FDA Letter to Health Care Providers Related to Intragastric Balloons Conference Call Scheduled for June 4, 2018 at 1:30 PM Pacific Time ...
23.10.17 - PR Newswire
EnteroMedics Announces Name Change to ReShape Lifesciences Inc. (NASDAQ: RSLS)
EnteroMedics Announces Name Change to ReShape Lifesciences Inc. (NASDAQ: RSLS) PR Newswire
16.10.17 - PR Newswire
EnteroMedics Announces Presentations at ObesityWeek 2017
EnteroMedics Announces Presentations at ObesityWeek 2017 PR Newswire
12.10.17 - PR Newswire
EnteroMedics Announces New Employee Inducement Option Grants
EnteroMedics Announces New Employee Inducement Option Grants PR Newswire
03.10.17 - PR Newswire
EnteroMedics Announces Acquisition Of ReShape Medical
EnteroMedics Announces Acquisition Of ReShape Medical Acquisition Adds Approved, Revenue-​Generating Balloon Technology for Obesity Conference Call and Webcast Today at ...
05.09.17 - PR Newswire
EnteroMedics Begins Post-Approval Study for the Treatment of Obesity with vBloc Therapy
EnteroMedics Begins Post-​Approval Study for the Treatment of Obesity with vBloc Therapy Study Designed to Further Demonstrate Long-Term Safety and Efficacy of vBloc for Weight ...
28.08.17 - PR Newswire
Study Concludes Vagal Nerve Blocking with EnteroMedics' vBloc Therapy is Cost-Effective
Study Concludes Vagal Nerve Blocking with EnteroMedics' vBloc Therapy is Cost-​Effective vBloc Therapy Cost-​Effectiveness Analysis Published in the American Journal of Managed ...
21.08.17 - PR Newswire
EnteroMedics Announces First Veterans Choice Program vBloc® Implant at MedStar Health in Maryland
EnteroMedics Announces First Veterans Choice Program vBloc® Implant at MedStar Health in Maryland PR Newswire

Newssuche

Videos

newspaper
07.05.24 +43,15%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »